1. Home
  2. CTOR vs RVPH Comparison

CTOR vs RVPH Comparison

Compare CTOR & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTOR
  • RVPH
  • Stock Information
  • Founded
  • CTOR 2021
  • RVPH 2006
  • Country
  • CTOR United States
  • RVPH United States
  • Employees
  • CTOR N/A
  • RVPH N/A
  • Industry
  • CTOR
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTOR
  • RVPH Health Care
  • Exchange
  • CTOR NYSE
  • RVPH Nasdaq
  • Market Cap
  • CTOR 89.9M
  • RVPH 88.0M
  • IPO Year
  • CTOR N/A
  • RVPH N/A
  • Fundamental
  • Price
  • CTOR $1.25
  • RVPH $1.98
  • Analyst Decision
  • CTOR Strong Buy
  • RVPH Strong Buy
  • Analyst Count
  • CTOR 2
  • RVPH 5
  • Target Price
  • CTOR $4.50
  • RVPH $11.40
  • AVG Volume (30 Days)
  • CTOR 104.8K
  • RVPH 2.2M
  • Earning Date
  • CTOR 02-21-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • CTOR N/A
  • RVPH N/A
  • EPS Growth
  • CTOR N/A
  • RVPH N/A
  • EPS
  • CTOR N/A
  • RVPH N/A
  • Revenue
  • CTOR N/A
  • RVPH N/A
  • Revenue This Year
  • CTOR N/A
  • RVPH N/A
  • Revenue Next Year
  • CTOR N/A
  • RVPH N/A
  • P/E Ratio
  • CTOR N/A
  • RVPH N/A
  • Revenue Growth
  • CTOR N/A
  • RVPH N/A
  • 52 Week Low
  • CTOR $0.85
  • RVPH $0.60
  • 52 Week High
  • CTOR $49.00
  • RVPH $4.83
  • Technical
  • Relative Strength Index (RSI)
  • CTOR N/A
  • RVPH 56.56
  • Support Level
  • CTOR N/A
  • RVPH $1.78
  • Resistance Level
  • CTOR N/A
  • RVPH $1.91
  • Average True Range (ATR)
  • CTOR 0.00
  • RVPH 0.18
  • MACD
  • CTOR 0.00
  • RVPH -0.00
  • Stochastic Oscillator
  • CTOR 0.00
  • RVPH 86.00

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: